 | Up a level |
Al Hamed, Rama; Labopin, Myriam; Wu, Depei; Gedde-Dahl, Tobias; Aljurf, Mahmoud; Forcade, Edouard; Salmenniemi, Urpu; Passweg, Jakob; Maertens, Johan; Pabst, Thomas; Versluis, Jurjen; Itäla-Remes, Maija; Huang, Xiao-Jun; Van Gorkom, Gwendolyn; Schroeder, Thomas; Sanz, Jaime; Blaise, Didier; Reményi, Péter; Schanz, Urs; Esteve, Jordi; ... (2024). Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT. (In Press). Bone marrow transplantation Springer Nature 10.1038/s41409-024-02373-5
Chen, Jia; Labopin, Myriam; Pabst, Thomas; Zhang, Xi; Jiang, Erlie; Tucci, Alessandra; Cornelissen, Jan; Meijer, Ellen; Khevelidze, Irma; Polge, Emmanuelle; Wu, Depei; Mohty, Mohamad; Gorin, Norbert-Claude (2023). Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT. Bone marrow transplantation, 58(12), pp. 1322-1330. Nature Publishing Group 10.1038/s41409-023-02070-9
Gorin, Norbert-Claude; Labopin, Myriam; Pabst, Thomas; Remenyi, Peter; Wu, Depei; Huynh, Anne; Volin, Liisa; Cahn, Jean Yves; Yakoub-Agha, Ibrahim; Mercier, Melanie; Houhou, Mohamed; Mohty, Mohamad; Nagler, Arnon (2017). Unrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remission. American journal of hematology, 92(12), pp. 1318-1323. Wiley-Liss 10.1002/ajh.24904
Gorin, Norbert-Claude; Labopin, Myriam; Czerw, Tomasz; Pabst, Thomas; Blaise, Didier; Dumas, Pierre-Yves; Nemet, Damir; Arcese, William; Trisolini, Silvia Maria; Wu, Depei; Huynh, Anne; Zuckerman, Tsila; Meijer, Ellen; Cagirgan, Seckin; Cornelissen, Jan; Houhou, Mohamed; Polge, Emmanuelle; Mohty, Mohamad; Nagler, Arnon (2017). Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Cancer, 123(5), pp. 824-831. John Wiley & Sons 10.1002/cncr.30400
